212 related articles for article (PubMed ID: 30412857)
21. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
22. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
23. DEK modulates both expression and alternative splicing of cancer‑related genes.
Liu B; Sun Y; Zhang Y; Xing Y; Suo J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35475534
[TBL] [Abstract][Full Text] [Related]
24. In silico gene expression and pathway analysis of DEK in the human brain across the lifespan.
Greene AN; Nguyen ET; Paranjpe A; Lane A; Privette Vinnedge LM; Solomon MB
Eur J Neurosci; 2022 Sep; 56(6):4720-4743. PubMed ID: 35972263
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
[TBL] [Abstract][Full Text] [Related]
26. Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2.
Özçelik E; Kalaycı A; Çelik B; Avcı A; Akyol H; Kılıç İB; Güzel T; Çetin M; Öztürk MT; Çalışkaner ZO; Tombaz M; Yoleri D; Konu Ö; Kandilci A
PLoS One; 2022; 17(10):e0275476. PubMed ID: 36190960
[TBL] [Abstract][Full Text] [Related]
28. LCMR1 interacts with DEK to suppress apoptosis in lung cancer cells.
Xu Y; Liang Z; Li C; Yang Z; Chen L
Mol Med Rep; 2017 Oct; 16(4):4159-4164. PubMed ID: 28765911
[TBL] [Abstract][Full Text] [Related]
29. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
[TBL] [Abstract][Full Text] [Related]
30. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.
Fahrer J; Popp O; Malanga M; Beneke S; Markovitz DM; Ferrando-May E; Bürkle A; Kappes F
Biochemistry; 2010 Aug; 49(33):7119-30. PubMed ID: 20669926
[TBL] [Abstract][Full Text] [Related]
31. Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization.
Nakashima T; Tomita H; Hirata A; Ishida K; Hisamatsu K; Hatano Y; Kanayama T; Niwa A; Noguchi K; Kato K; Miyazaki T; Tanaka T; Shibata T; Hara A
Cancer Med; 2017 Oct; 6(10):2424-2439. PubMed ID: 28834425
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.
Wise-Draper TM; Allen HV; Jones EE; Habash KB; Matsuo H; Wells SI
Mol Cell Biol; 2006 Oct; 26(20):7506-19. PubMed ID: 16894028
[TBL] [Abstract][Full Text] [Related]
33. Neuroanatomical Distribution of DEK Protein in Corticolimbic Circuits Associated with Learning and Memory in Adult Male and Female Mice.
Ghisays V; Nguyen ET; Streicher J; Pease NA; Fitzgerald M; Estrada CM; Franco-Villanueva A; Privette Vinnedge L; Solomon MB
Neuroscience; 2018 Feb; 371():254-267. PubMed ID: 29175155
[TBL] [Abstract][Full Text] [Related]
34. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.
Deutzmann A; Ganz M; Schönenberger F; Vervoorts J; Kappes F; Ferrando-May E
Oncogene; 2015 Aug; 34(32):4270-7. PubMed ID: 25347734
[TBL] [Abstract][Full Text] [Related]
35. The nuclear DEK interactome supports multi-functionality.
Smith EA; Krumpelbeck EF; Jegga AG; Prell M; Matrka MM; Kappes F; Greis KD; Ali AM; Meetei AR; Wells SI
Proteins; 2018 Jan; 86(1):88-97. PubMed ID: 29082557
[TBL] [Abstract][Full Text] [Related]
36. DEK over-expression promotes mitotic defects and micronucleus formation.
Matrka MC; Hennigan RF; Kappes F; DeLay ML; Lambert PF; Aronow BJ; Wells SI
Cell Cycle; 2015; 14(24):3939-53. PubMed ID: 25945971
[TBL] [Abstract][Full Text] [Related]
37. Intercellular trafficking of the nuclear oncoprotein DEK.
Saha AK; Kappes F; Mundade A; Deutzmann A; Rosmarin DM; Legendre M; Chatain N; Al-Obaidi Z; Adams BS; Ploegh HL; Ferrando-May E; Mor-Vaknin N; Markovitz DM
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6847-52. PubMed ID: 23569252
[TBL] [Abstract][Full Text] [Related]
38. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
39. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract][Full Text] [Related]
40. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells.
Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S
Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
